• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质醇对肾上腺偶发瘤和库欣综合征患者肝脏脂肪及代谢健康的影响。

Impact of cortisol on liver fat and metabolic health in adrenal incidentalomas and Cushing's syndrome.

作者信息

Yu Peng, Yuan Haoyue, Li Xiaomu, Chen Hong

机构信息

Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.

Department of Endocrinology and Metabolism, Shanghai Geriatric Medical Center, Shanghai, China.

出版信息

Endocrine. 2025 Jan;87(1):334-343. doi: 10.1007/s12020-024-04043-4. Epub 2024 Sep 25.

DOI:10.1007/s12020-024-04043-4
PMID:39320593
Abstract

OBJECTIVE

To evaluate liver fat content in patients with non-functional adrenal incidentalomas (NFAI), mild autonomous cortisol secretion (MACS), and Cushing's syndrome (CS), and assess its relationship with cortisol levels.

METHODS

This cross-sectional study used retrospective data from 103 NFAI patients, 100 MACS (serum cortisol after a 1-mg dexamethasone test >50 nmol/L), and 59 with CS. Abdominal CT scans measured hepatic and splenic CT values to calculate the liver-to-spleen (L/S) ratio. Metabolic indicators including fasting plasma glucose (FPG), LDL-c, HDL-c, HbA1c, etc were measured. Mediation analysis was used to explore the indirect effects of metabolic traits on the cortisol-liver fat relationship.

RESULTS

Patients included 103 NFAI, 100 MACS, and 59 CS. MACS patients had higher NAFLD prevalence (57%) than NFAI (26.2%, p < 0.001) but lower than CS (66.1%, p < 0.001). MACS and CS were associated with NAFLD (OR 3.83 and OR 5.73, p < 0.01), adjusted for age, body mass index (BMI), and covariates. Midnight serum cortisol correlated with L/S ratio (p < 0.001). HbA1c and Triglyceride-glucose index (TyG) mediated 24.5% and 49.5% of the cortisol and L/S ratio association, respectively. FPG, HbA1c, HDL-c, and TyG mediated the association between MACS or CS and the L/S ratio. Homeostasis model assessment of insulin resistance (HOMA-IR), fructosamine, and triglycerides mediated for MACS, while alkaline phosphatase did so for CS. Total cholesterol, LDL-c, ALT, AST, γ-GT, insulin, and uric acid did not mediate the association.

CONCLUSION

MACS and CS are linked to significant metabolic disturbances, including increased liver fat and impaired glucose and lipid metabolism, contributing to fatty liver.

摘要

目的

评估无功能肾上腺偶发瘤(NFAI)、轻度自主性皮质醇分泌(MACS)和库欣综合征(CS)患者的肝脏脂肪含量,并评估其与皮质醇水平的关系。

方法

这项横断面研究使用了103例NFAI患者、100例MACS患者(1毫克地塞米松试验后血清皮质醇>50 nmol/L)和59例CS患者的回顾性数据。腹部CT扫描测量肝脏和脾脏的CT值以计算肝脾比(L/S)。测量包括空腹血糖(FPG)、低密度脂蛋白胆固醇(LDL-c)、高密度脂蛋白胆固醇(HDL-c)、糖化血红蛋白(HbA1c)等代谢指标。采用中介分析来探讨代谢特征对皮质醇与肝脏脂肪关系的间接影响。

结果

患者包括103例NFAI、100例MACS和59例CS。MACS患者的非酒精性脂肪性肝病(NAFLD)患病率(57%)高于NFAI患者(26.2%,p<0.001),但低于CS患者(66.1%,p<0.001)。在调整年龄、体重指数(BMI)和协变量后,MACS和CS与NAFLD相关(OR分别为3.83和5.73,p<0.01)。午夜血清皮质醇与L/S比相关(p<0.001)。糖化血红蛋白(HbA1c)和甘油三酯-葡萄糖指数(TyG)分别介导了皮质醇与L/S比关联的24.5%和49.5%。FPG、HbA1c、HDL-c和TyG介导了MACS或CS与L/S比之间的关联。胰岛素抵抗稳态模型评估(HOMA-IR)、果糖胺和甘油三酯介导了MACS与L/S比的关联,而碱性磷酸酶介导了CS与L/S比的关联。总胆固醇、LDL-c、谷丙转氨酶(ALT)、谷草转氨酶(AST)、γ-谷氨酰转肽酶(γ-GT)、胰岛素和尿酸未介导这种关联。

结论

MACS和CS与显著的代谢紊乱有关,包括肝脏脂肪增加以及糖脂代谢受损,进而导致脂肪肝。

相似文献

1
Impact of cortisol on liver fat and metabolic health in adrenal incidentalomas and Cushing's syndrome.皮质醇对肾上腺偶发瘤和库欣综合征患者肝脏脂肪及代谢健康的影响。
Endocrine. 2025 Jan;87(1):334-343. doi: 10.1007/s12020-024-04043-4. Epub 2024 Sep 25.
2
Fibroblast growth factor 21 in patients with mild autonomic cortisol secretion and non-functioning adrenal incidentalomas.轻度自主性皮质醇分泌和无功能肾上腺偶发瘤患者的成纤维细胞生长因子21
Endokrynol Pol. 2024;75(6):672-683. doi: 10.5603/ep.102598.
3
Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?无功能和自主分泌皮质醇的肾上腺意外瘤的心脏代谢特征。心血管代谢风险是否相似还是存在差异?
Endocrine. 2019 Dec;66(3):650-659. doi: 10.1007/s12020-019-02066-w. Epub 2019 Aug 31.
4
Prevalence and Predictive Features of CT-Derived Nonalcoholic Fatty Liver Disease in Metabolically Healthy MACS.代谢健康的MACS中CT衍生的非酒精性脂肪性肝病的患病率及预测特征
Clin Endocrinol (Oxf). 2025 Apr;102(4):380-388. doi: 10.1111/cen.15194. Epub 2025 Jan 2.
5
Diabetes Mellitus in Non-Functioning Adrenal Incidentalomas: Analysis of the Mild Autonomous Cortisol Secretion (MACS) Impact on Glucose Profile.无功能肾上腺偶发瘤中的糖尿病:轻度自主性皮质醇分泌(MACS)对血糖谱影响的分析
Biomedicines. 2024 Jul 18;12(7):1606. doi: 10.3390/biomedicines12071606.
6
Metabolic, hormonal profiles and comorbidities in pituitary Cushing's syndrome, adrenal Cushing's syndrome and mild autonomous cortisol secretion: a comparative study.垂体性库欣综合征、肾上腺性库欣综合征及轻度自主性皮质醇分泌的代谢、激素谱和合并症:一项比较研究。
Postgrad Med. 2025 Mar;137(2):182-188. doi: 10.1080/00325481.2025.2455373. Epub 2025 Jan 19.
7
The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.肾上腺偶发瘤患者的小剂量地塞米松抑制试验:与临床肾上腺功能正常者及库欣综合征患者的比较
Clin Endocrinol (Oxf). 1998 May;48(5):627-33. doi: 10.1046/j.1365-2265.1998.00464.x.
8
Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma.肾上腺意外瘤患者内脏脂肪堆积与地塞米松后血清皮质醇水平。
J Clin Endocrinol Metab. 2013 Jun;98(6):2383-91. doi: 10.1210/jc.2012-4276. Epub 2013 Apr 30.
9
Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study.内源性皮质醇过多时的心血管状况:前瞻性CV-CORT-EX研究
Eur J Endocrinol. 2024 Nov 27;191(6):604-613. doi: 10.1093/ejendo/lvae145.
10
Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.库欣综合征患者和偶发瘤及亚临床皮质醇增多症患者肾上腺腺瘤切除术后即刻下丘脑-垂体-肾上腺功能的改变。
Endocrine. 2019 Jan;63(1):140-148. doi: 10.1007/s12020-018-1769-z. Epub 2018 Sep 27.

本文引用的文献

1
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease.糖皮质激素在代谢相关脂肪性肝病中的作用。
Curr Obes Rep. 2024 Jun;13(2):242-255. doi: 10.1007/s13679-024-00556-1. Epub 2024 Mar 8.
2
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.一项评估 Resmetirom 治疗伴有肝纤维化的 NASH 的 3 期随机对照试验。
N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000.
3
Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study.
纤维化-4指数对肥胖和/或2型糖尿病个体发生后续肝脏和心血管事件风险及全因死亡率的预后价值:一项纵向队列研究
Lancet Reg Health Eur. 2023 Dec 19;36:100780. doi: 10.1016/j.lanepe.2023.100780. eCollection 2024 Jan.
4
Cushing Syndrome Is Associated With Gut Microbial Dysbiosis and Cortisol-Degrading Bacteria.库欣综合征与肠道微生物失调和皮质醇降解细菌有关。
J Clin Endocrinol Metab. 2024 May 17;109(6):1474-1484. doi: 10.1210/clinem/dgad766.
5
Cardiovascular Risk Markers in Adults With Adrenal Incidentaloma and Mild Autonomous Cortisol Secretion.成年人肾上腺意外瘤伴轻度自主皮质醇分泌的心血管风险标志物。
J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1020-e1028. doi: 10.1210/clinem/dgad665.
6
Increased Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion.轻度自主皮质醇分泌患者的椎体骨折风险增加。
J Clin Endocrinol Metab. 2024 Jan 18;109(2):e623-e632. doi: 10.1210/clinem/dgad560.
7
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.欧洲内分泌学会与欧洲肾上腺肿瘤研究网络合作制定的关于肾上腺意外瘤处理的临床实践指南。
Eur J Endocrinol. 2023 Jul 20;189(1):G1-G42. doi: 10.1093/ejendo/lvad066.
8
Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis.影响肝内脂肪与胰内脂肪关系的代谢特征:中介分析。
Diabetologia. 2023 Jan;66(1):190-200. doi: 10.1007/s00125-022-05793-4. Epub 2022 Oct 4.
9
Management and Medical Therapy of Mild Hypercortisolism.轻度过量皮质醇症的管理和医学治疗。
Int J Mol Sci. 2021 Oct 26;22(21):11521. doi: 10.3390/ijms222111521.
10
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.非酒精性脂肪性肝病、胰岛素抵抗、代谢综合征及其与血管风险的关系。
Metabolism. 2021 Jun;119:154770. doi: 10.1016/j.metabol.2021.154770. Epub 2021 Apr 14.